1
|
Boudia F, Baille M, Babin L, Aid Z, Robert E, Rivière J, Galant K, Alonso-Pérez V, Anselmi L, Arkoun B, Abermil N, Marzac C, Bertuccio SN, de Prémesnil A, Lopez CK, Eeckhoutte A, Naimo A, Leite B, Catelain C, Metereau C, Gonin P, Gaspar N, Schwaller J, Bernard OA, Raslova H, Gaudry M, Marchais A, Lapillonne H, Petit A, Pflumio F, Arcangeli ML, Brunet E, Mercher T. Progressive chromatin rewiring by ETO2::GLIS2 revealed in a genome-edited human iPSC model of pediatric leukemia initiation. Blood 2025; 145:1510-1525. [PMID: 39656971 DOI: 10.1182/blood.2024024505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Revised: 09/10/2024] [Accepted: 09/26/2024] [Indexed: 12/17/2024] Open
Abstract
ABSTRACT Pediatric acute myeloid leukemia frequently harbors fusion oncogenes associated with poor prognosis, including KMT2A, NUP98, and GLIS2 rearrangements. Although murine models have demonstrated their leukemogenic activities, the steps from a normal human cell to leukemic blasts remain unclear. Here, we precisely reproduced the inversion of chromosome 16 resulting in the ETO2::GLIS2 fusion in human induced pluripotent stem cells (iPSCs). iPSC-derived ETO2::GLIS2-expressing hematopoietic cells showed differentiation alterations in vitro and efficiently induced in vivo development of leukemia that closely phenocopied human acute megakaryoblastic leukemia (AMKL), reflected by flow cytometry and single-cell transcriptomes. Comparison of iPS-derived cells with patient-derived cells revealed altered chromatin accessibility at early and later bona fide leukemia stages, with aberrantly higher accessibility and expression of the osteogenic homeobox factor DLX3 that preceded increased accessibility to ETS factors. DLX3 overexpression in normal CD34+ cells increased accessibility to ETS motifs and reduced accessibility to GATA motifs. A DLX3 transcriptional module was globally enriched in both ETO2::GLIS2 AMKL and some aggressive pediatric osteosarcoma. Importantly, DLX3 knockout abrogated leukemia initiation in this ETO2::GLIS2 iPSC model. Collectively, the characterization of a novel human iPSC-derived AMKL model revealed that hijacking of the osteogenic homeobox transcription factor DLX3 is an essential early step in chromatin changes and leukemogenesis driven by the ETO2::GLIS2 fusion oncogene.
Collapse
MESH Headings
- Humans
- Induced Pluripotent Stem Cells/metabolism
- Induced Pluripotent Stem Cells/pathology
- Oncogene Proteins, Fusion/genetics
- Oncogene Proteins, Fusion/metabolism
- Chromatin/metabolism
- Chromatin/genetics
- Animals
- Mice
- Gene Editing
- Child
- Proto-Oncogene Proteins/genetics
- Proto-Oncogene Proteins/metabolism
- DNA-Binding Proteins/genetics
- DNA-Binding Proteins/metabolism
- Leukemia, Megakaryoblastic, Acute/genetics
- Leukemia, Megakaryoblastic, Acute/pathology
- Leukemia, Megakaryoblastic, Acute/metabolism
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/pathology
- Leukemia, Myeloid, Acute/metabolism
- Transcription Factors/genetics
- Transcription Factors/metabolism
Collapse
Affiliation(s)
- Fabien Boudia
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
- Université Paris Cité, Paris, France
| | - Marie Baille
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
- Université Paris Cité, Paris, France
| | - Loélia Babin
- Laboratory of the Genome Dynamics in the Immune System, Institut Imagine, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Paris, France
| | - Zakia Aid
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Elie Robert
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Julie Rivière
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Klaudia Galant
- UMR-E008, Stabilité Génétique, Cellules Souches et Radiations, Team Niche and Cancer in Hematopoiesis, Commissariat à l'Energie Atomique et aux Energies Alternatives, Université de Paris-Université Paris-Saclay, Fontenay-aux-Roses, France
| | - Verónica Alonso-Pérez
- UMR-E008, Stabilité Génétique, Cellules Souches et Radiations, Team Niche and Cancer in Hematopoiesis, Commissariat à l'Energie Atomique et aux Energies Alternatives, Université de Paris-Université Paris-Saclay, Fontenay-aux-Roses, France
| | - Laura Anselmi
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- University of Bologna, Bologna, Italy
| | - Brahim Arkoun
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Gustave Roussy, INSERM U1287, Université Paris-Saclay, Équipe Labellisée La Ligue Contre Le Cancer, Villejuif, France
| | - Nassera Abermil
- Laboratoire d'Hématologie Biologique, Hôpital Universitaire Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Christophe Marzac
- Department of Hematology, Leukemia Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Villejuif, France
| | | | - Alexia de Prémesnil
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Université Paris Cité, Paris, France
| | - Cécile K Lopez
- Department of Haematology, University of Cambridge, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom
| | - Alexandre Eeckhoutte
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Audrey Naimo
- Gustave Roussy, Genomic Platform, Université Paris-Saclay, Unité Mixte de Service AMMICA, INSERM US23, Centre National de la Recherche Scientifique UMS 3655, Villejuif, France
| | - Betty Leite
- Gustave Roussy, Genomic Platform, Université Paris-Saclay, Unité Mixte de Service AMMICA, INSERM US23, Centre National de la Recherche Scientifique UMS 3655, Villejuif, France
| | - Cyril Catelain
- Gustave Roussy, Plateforme Imagerie et Cytométrie, Université Paris-Saclay, Unité Mixte de Service AMMICA, INSERM US23, Centre National de la Recherche Scientifique UMS 3655, Villejuif, France
| | - Christophe Metereau
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Patrick Gonin
- Gustave Roussy Cancer Center, Université Paris-Saclay, UMS AMMICA, Villejuif, France
| | - Nathalie Gaspar
- Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France
| | - Jürg Schwaller
- University Children's Hospital Beider Basel and Department of Biomedicine, University of Basel, Basel, Switzerland
| | - Olivier A Bernard
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Hana Raslova
- Gustave Roussy, INSERM U1287, Université Paris-Saclay, Équipe Labellisée La Ligue Contre Le Cancer, Villejuif, France
| | - Muriel Gaudry
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Antonin Marchais
- Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France
| | - Hélène Lapillonne
- Department of Pediatric Hematology and Oncology, Laboratory of Hematology, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
- Sorbonne Université, INSERM, UMRS_938, Centre de Recherche Saint-Antoine, Paris, France
| | - Arnaud Petit
- Department of Pediatric Hematology and Oncology, Laboratory of Hematology, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
- Sorbonne Université, INSERM, UMRS_938, Centre de Recherche Saint-Antoine, Paris, France
- OPALE Carnot Institute, Paris, France
| | - Françoise Pflumio
- UMR-E008, Stabilité Génétique, Cellules Souches et Radiations, Team Niche and Cancer in Hematopoiesis, Commissariat à l'Energie Atomique et aux Energies Alternatives, Université de Paris-Université Paris-Saclay, Fontenay-aux-Roses, France
- OPALE Carnot Institute, Paris, France
| | - Marie-Laure Arcangeli
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
| | - Erika Brunet
- Equipe labellisée Ligue Contre le Cancer, Paris, France
- Université Paris Cité, Paris, France
- Laboratory of the Genome Dynamics in the Immune System, Institut Imagine, Université de Paris, Université Paris Saclay, INSERM UMR 1163, Paris, France
| | - Thomas Mercher
- Gustave Roussy, PEDIAC program, INSERM U1170, Université Paris-Saclay, Villejuif, France
- Equipe labellisée Ligue Contre le Cancer, Paris, France
- OPALE Carnot Institute, Paris, France
| |
Collapse
|
2
|
O'Neill CG, Sawaya AP, Mehdizadeh S, Brooks SR, Hasneen K, Nayak S, Overmiller AM, Morasso MI. SOX2-Dependent Wound Repair Signature Triggers Prohealing Outcome in Hyperglycemic Wounds. J Invest Dermatol 2025; 145:451-455.e5. [PMID: 39127091 PMCID: PMC11745936 DOI: 10.1016/j.jid.2024.07.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Revised: 07/15/2024] [Accepted: 07/17/2024] [Indexed: 08/12/2024]
Affiliation(s)
- Christopher G O'Neill
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Andrew P Sawaya
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Spencer Mehdizadeh
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Stephen R Brooks
- Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Kowser Hasneen
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Subhashree Nayak
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Andrew M Overmiller
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
| | - Maria I Morasso
- Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
| |
Collapse
|
3
|
Szabó K, Balogh F, Romhányi D, Erdei L, Toldi B, Gyulai R, Kemény L, Groma G. Epigenetic Regulatory Processes Involved in the Establishment and Maintenance of Skin Homeostasis-The Role of Microbiota. Int J Mol Sci 2025; 26:438. [PMID: 39859154 PMCID: PMC11764776 DOI: 10.3390/ijms26020438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2024] [Revised: 12/30/2024] [Accepted: 01/02/2025] [Indexed: 01/27/2025] Open
Abstract
Epigenetic mechanisms are central to the regulation of all biological processes. This manuscript reviews the current understanding of diverse epigenetic modifications and their role in the establishment and maintenance of normal skin functions. In healthy skin, these mechanisms allow for the precise control of gene expression, facilitating the dynamic balance between cell proliferation and differentiation necessary for effective barrier function. Furthermore, as the skin ages, alterations in epigenetic marks can lead to impaired regenerative capacity and increased susceptibility to environmental stressors. The interaction between skin microbiota and epigenetic regulation will also be explored, highlighting how microbial communities can influence skin health by modulating the host gene expression. Future research should focus on the development of targeted interventions to promote skin development, resilience, and longevity, even in an ever-changing environment. This underscores the need for integrative approaches to study these complex regulatory networks.
Collapse
Affiliation(s)
- Kornélia Szabó
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
- HCEMM-USZ Skin Research Group, 6720 Szeged, Hungary
| | - Fanni Balogh
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
| | - Dóra Romhányi
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
| | - Lilla Erdei
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
- HCEMM-USZ Skin Research Group, 6720 Szeged, Hungary
| | - Blanka Toldi
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
| | - Rolland Gyulai
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
| | - Lajos Kemény
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
- HCEMM-USZ Skin Research Group, 6720 Szeged, Hungary
| | - Gergely Groma
- HUN-REN-SZTE Dermatological Research Group, 6720 Szeged, Hungary (L.K.); (G.G.)
- Department of Dermatology and Allergology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary
| |
Collapse
|